Skip to content

Drug interactions

Bexarotene + Linagliptin

Severity: Moderate

Bexarotene and Linagliptin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Bexarotene is a CYP3A4 inducer and may lower linagliptin concentrations, potentially weakening glucose control. The direction of effect is reduction, and the magnitude is uncertain.

What this interaction means in plain words

Bexarotene and Linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bexarotene belongs to Oncology; Linagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

Induction of CYP3A4 (and possibly P-gp) by bexarotene increases linagliptin clearance.

What to do

Monitor glucose and HbA1c, and add or switch antidiabetic therapy if control deteriorates.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bexarotene and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Bexarotene with Linagliptin?

MediHelp rates the interaction as moderate. Bexarotene and Linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bexarotene is a CYP3A4 inducer and may lower linagliptin concentrations, potentially weakening glucose control. The direction of effect is reduction, and the magnitude is uncertain.

How serious is the interaction between Bexarotene and Linagliptin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor glucose and HbA1c, and add or switch antidiabetic therapy if control deteriorates.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in